| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $68.01 | $17.87 | 280.49% | 283.38x | 19.91x | 20.78x | 55.70x | 1.39x | $41.15M | 0.69% | $108.58M | 1.23 | $6.01B | 112.13 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $6.90 | $2.96 | 133.08% | 98.57x | 64.43x | 3.74x | 91.56x | 0.91x | $47.52M | 4.04% | $13.01M | 0.08 | $1.34B | 25.04 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $281.90 | $94.66 | 197.81% | 64.66x | 37.38x | 8.74x | 35.00x | 1.34x | $641.34M | 1.71% | $1.08B | 8.09 | $38.90B | 42.07 | ||
| CORT | CORCEPT THERAPEUTICS INC | $83.71 | $21.00 | 298.60% | 181.98x | 159.87x | 11.37x | 14.09x | 1.54x | $119.79M | 1.37% | $637.99M | 6.11 | $8.89B | -1,294.39 | ||
| KRYS | KRYSTAL BIOTECH INC | $323.37 | $96.55 | 234.93% | 41.73x | 40.67x | 22.70x | 7.47x | 1.99x | $237.38M | 2.51% | $1.28B | 43.59 | $9.04B | 42.25 | ||
| HALO | HALOZYME THERAPEUTICS INC | $69.64 | $72.21 | -3.56% | 23.53x | 8.40x | 5.45x | 37.61x | 0.42x | $667.65M | 8.11% | $219.64M | 1.86 | $10.09B | 16.18 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $52.30 | $17.53 | 198.30% | 53.37x | 40.96x | 5.31x | 6.64x | 1.45x | $164.23M | 4.10% | $605.69M | 7.92 | $3.84B | 34.47 | ||
| ADMA | ADMA BIOLOGICS INC | $8.58 | $9.81 | -12.51% | 12.43x | 9.38x | 3.97x | 5.09x | 0.48x | $107.90M | 5.33% | $390.33M | 1.65 | $2.05B | 9.25 | ||
| ASND | ASCENDIS PHARMA A | $231.20 | $81.68 | 183.06% | 24.50x | 15.50x | 14.10x | 25.01x | 2.51x | $52.94M | 0.37% | $574.09M | 9.24 | $14.74B | 158.07 | ||
| VCEL | VERICEL CORP | $38.46 | $9.25 | 315.88% | 89.44x | 79.78x | 6.69x | 5.51x | 1.88x | $47.49M | 2.43% | $356.23M | 7.02 | $1.95B | 48.23 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $12.65 | $16.16 | -21.73% | 6.17x | 26.39x | 6.04x | 3.63x | 0.82x | $56.42M | 7.64% | $205.80M | 3.52 | $653.36M | 4.52 | ||
| RPRX | ROYALTY PHARMA PLC | $54.21 | $40.37 | 34.28% | 28.38x | 10.16x | 9.70x | 3.14x | 0.61x | $2.34B | 9.89% | $9.94B | 22.75 | $39.59B | 34.03 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $55.12 | $42.29 | 30.34% | 39.37x | 14.54x | 3.27x | 1.72x | 0.54x | $767.06M | 7.23% | $6.21B | 32.27 | $9.01B | 18.68 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $226.88 | $50.00 | 353.72% | 482.72x | 8.82x | 3.16x | 3.14x | 1.62x | $1.30B | 9.24% | $4.53B | 73.22 | $17.79B | 26.36 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $33.83 | $36.18 | -6.50% | 13.37x | 9.19x | 2.18x | 2.15x | 0.51x | $341.79M | 17.47% | $910.35M | 15.75 | $1.53B | 6.45 | ||
| TECH | BIO-TECHNE CORP | $56.03 | $15.51 | 261.34% | 78.92x | 28.56x | 7.23x | 4.21x | 1.63x | $269.60M | 3.08% | $2.09B | 13.34 | $8.85B | 34.59 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $255.25 | $95.54 | 167.18% | 32.31x | 28.12x | 18.49x | 5.13x | 1.63x | $122.22M | 2.41% | $997.32M | 50.16 | $5.45B | 24.17 | ||
| TGTX | TG THERAPEUTICS INC | $50.54 | $17.24 | 193.11% | 15.70x | 36.13x | 10.42x | 13.27x | 248.71x | -$14.19M | -0.19% | $583.13M | 4.04 | $8.05B | 53.63 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.77 | $5.80 | -52.28% | 10.26x | 4.05x | 2.59x | 3.03x | 0.22x | $7.24M | 4.55% | $52.93M | 0.92 | $106.73M | 6.89 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.43 | $2.49 | 37.78% | 14.29x | 14.50x | 2.10x | 3.32x | 0.96x | $4.11M | 1.49% | $82.33M | 1.03 | $209.21M | 9.85 | ||
| EXEL | EXELIXIS INC | $52.10 | $31.22 | 66.88% | 16.70x | 15.82x | 5.67x | 6.77x | 1.22x | $917.69M | 6.82% | $1.94B | 7.49 | $13.04B | 12.35 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.35 | $12.40 | 152.90% | 17.32x | 15.99x | 6.42x | 3.79x | 3.89x | $208.13M | 5.43% | $1.01B | 8.28 | $3.08B | 9.20 | ||
| UTHR | UNITED THERAPEUTICS CORP | $548.27 | $246.20 | 122.69% | 18.73x | 19.27x | 7.52x | 3.94x | 2.07x | $1.02B | 4.26% | $5.90B | 135.66 | $21.99B | 12.83 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $453.17 | $169.97 | 166.61% | 26.64x | 23.18x | 9.42x | 5.94x | 1.94x | $3.71B | 3.22% | $19.36B | 76.20 | $111.51B | 20.68 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $2.06 | $1.28 | 61.50% | 10.84x | 9.48x | 2.15x | 2.47x | 2.67x | $13.00M | 7.91% | $67.23M | 0.84 | $132.75M | 5.95 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $614.73 | $441.29 | 39.30% | 14.44x | 13.07x | 4.29x | 2.05x | 0.98x | $4.11B | 6.43% | $31.42B | 302.15 | $64.19B | 11.17 | ||
| INCY | INCYTE CORP | $99.75 | $67.67 | 47.40% | 13.68x | 12.73x | 3.71x | 3.54x | 1.18x | $1.45B | 7.30% | $5.62B | 28.21 | $16.50B | 8.82 | ||
| VCYT | VERACYTE INC | $50.92 | $7.69 | 561.93% | 45.87x | 45.66x | 7.48x | 3.02x | 9.77x | $155.34M | 3.84% | $1.34B | 16.90 | $3.84B | 33.36 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $15.78 | $3.65 | 332.21% | 26.30x | 4.31x | 0.76x | 1.11x | 11.90x | $109.24M | 6.59% | $1.51B | 14.34 | $2.24B | 27.05 | ||
| MDXG | MIMEDX GROUP INC | $3.70 | $1.27 | 191.29% | 17.62x | -43.94x | 1.41x | 2.27x | 8.38x | $69.36M | 12.62% | $242.94M | 1.64 | $408.92M | 7.51 |